Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2013; 34(03): 288-296
DOI: 10.1055/s-0033-1348468
DOI: 10.1055/s-0033-1348468
Lung Transplantation for Obstructive Lung Diseases
Further Information
Publication History
Publication Date:
02 July 2013 (online)
Abstract
Chronic obstructive pulmonary disease (COPD) represents one of the most common indications for lung transplantation, accounting for approximately one third of all procedures performed worldwide to date. Despite this extensive experience, questions remain about the appropriate timing of transplantation in the natural history of COPD, the optimal procedure to perform, and the survival benefit achieved. Less commonly encountered obstructive lung disorders for which transplantation is occasionally performed include emphysema due to α-1-antitrypsin deficiency, lymphangioleiomyomatosis, and Langerhans cell histiocytosis. Like COPD, the application of transplantation to these rare disorders also poses several questions. This article explores issues that arise when lung transplantation is utilized for treatment of both common and uncommon obstructive lung disorders.
-
References
- 1 Christie JD, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31 (10) 1073-1086
- 2 Vestbo J, Edwards LD, Scanlon PD , et al; ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365 (13) 1184-1192
- 3 Nishimura M, Makita H, Nagai K , et al; Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185 (1) 44-52
- 4 Martinez FJ, Kotloff R. Prognostication in chronic obstructive pulmonary disease: implications for lung transplantation. Semin Respir Crit Care Med 2001; 22 (5) 489-498
- 5 Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119 (6) 895-902
- 6 Celli BR, Cote CG, Marin JM , et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350 (10) 1005-1012
- 7 Martinez FJ, Han MK, Andrei AC , et al; National Emphysema Treatment Trial Research Group. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008; 178 (5) 491-499
- 8 Orens JB, Estenne M, Arcasoy S , et al; Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25 (7) 745-755
- 9 Egan TM, Kotloff RM. Pro/Con debate: lung allocation should be based on medical urgency and transplant survival and not on waiting time. Chest 2005; 128 (1) 407-415
- 10 Yusen RD, Shearon TH, Qian Y , et al. Lung transplantation in the United States, 1999-2008. Am J Transplant 2010; 10 (4 Pt 2) 1047-1068
- 11 McCurry KR, Shearon TH, Edwards LB , et al. Lung transplantation in the United States, 1998-2007. Am J Transplant 2009; 9 (4 Pt 2) 942-958
- 12 Fishman A, Martinez F, Naunheim K , et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348 (21) 2059-2073
- 13 Meyers BF, Yusen RD, Guthrie TJ , et al. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation. J Thorac Cardiovasc Surg 2001; 122 (1) 10-17
- 14 Senbaklavaci O, Wisser W, Ozpeker C , et al. Successful lung volume reduction surgery brings patients into better condition for later lung transplantation. Eur J Cardiothorac Surg 2002; 22 (3) 363-367
- 15 Burns KE, Keenan RJ, Grgurich WF, Manzetti JD, Zenati MA. Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study. Ann Thorac Surg 2002; 73 (5) 1587-1593
- 16 Bavaria JE, Pochettino A, Kotloff RM , et al. Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1998; 115 (1) 9-17 , discussion 17–18
- 17 Stevens PM, Johnson PC, Bell RL, Beall Jr AC, Jenkins DE. Regional ventilation and perfusion after lung transplantation in patients with emphysema. N Engl J Med 1970; 282 (5) 245-249
- 18 Levine SM, Anzueto A, Peters JI , et al. Medium term functional results of single-lung transplantation for endstage obstructive lung disease. Am J Respir Crit Care Med 1994; 150 (2) 398-402
- 19 Mal H, Andreassian B, Pamela F , et al. Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis 1989; 140 (3) 797-802
- 20 Bavaria JE, Kotloff R, Palevsky H , et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1997; 113 (3) 520-527 , discussion 528
- 21 Pochettino A, Kotloff RM, Rosengard BR , et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg 2000; 70 (6) 1813-1818 , discussion 1818–1819
- 22 Sundaresan RS, Shiraishi Y, Trulock EP , et al. Single or bilateral lung transplantation for emphysema?. J Thorac Cardiovasc Surg 1996; 112 (6) 1485-1494 , discussion 1494–1495
- 23 Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001; 20 (9) 935-941
- 24 Thabut G, Christie JD, Ravaud P , et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008; 371 (9614) 744-751
- 25 Gaissert HA, Trulock EP, Cooper JD, Sundaresan RS, Patterson GA. Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1996; 111 (2) 296-306 , discussion 306–307
- 26 Bossenbroek L, ten Hacken NH, van der Bij W, Verschuuren EA, Koëter GH, de Greef MH. Cross-sectional assessment of daily physical activity in chronic obstructive pulmonary disease lung transplant patients. J Heart Lung Transplant 2009; 28 (2) 149-155
- 27 Gerbase MW, Spiliopoulos A, Rochat T, Archinard M, Nicod LP. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005; 128 (3) 1371-1378
- 28 Levy RD, Ernst P, Levine SM , et al. Exercise performance after lung transplantation. J Heart Lung Transplant 1993; 12 (1 Pt 1) 27-33
- 29 Williams TJ, Patterson GA, McClean PA, Zamel N, Maurer JR. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145 (1) 101-105
- 30 Hadjiliadis D, Davis RD, Palmer SM. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?. Chest 2002; 122 (4) 1168-1175
- 31 Burton CM, Iversen M, Mortensen J , et al. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?. J Heart Lung Transplant 2007; 26 (11) 1127-1134
- 32 Munson JC, Christie JD, Halpern SD. The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184 (11) 1282-1288
- 33 Arcasoy SM, Hersh C, Christie JD , et al. Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant 2001; 20 (10) 1044-1053
- 34 de Perrot M, Chernenko S, Waddell TK , et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease. J Clin Oncol 2004; 22 (21) 4351-4356
- 35 Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006; 25 (11) 1297-1301
- 36 Minai OA, Shah S, Mazzone P , et al. Bronchogenic carcinoma after lung transplantation: characteristics and outcomes. J Thorac Oncol 2008; 3 (12) 1404-1409
- 37 Weill D, Torres F, Hodges TN, Olmos JJ, Zamora MR. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant 1999; 18 (11) 1080-1087
- 38 Yonan NA, el-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya AK. Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant 1998; 17 (2) 192-201
- 39 Gavazzeni V, Iapichino G, Mascheroni D , et al. Prolonged independent lung respiratory treatment after single lung transplantation in pulmonary emphysema. Chest 1993; 103 (1) 96-100
- 40 Reece TB, Mitchell JD, Zamora MR , et al. Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 2008; 135 (4) 931-937
- 41 Anderson MB, Kriett JM, Kapelanski DP, Perricone A, Smith CM, Jamieson SW. Volume reduction surgery in the native lung after single lung transplantation for emphysema. J Heart Lung Transplant 1997; 16 (7) 752-757
- 42 Venuta F, De Giacomo T, Rendina EA , et al. Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema. Am J Respir Crit Care Med 1997; 156: 292-293
- 43 Crespo MM, Johnson BA, McCurry KR, Landreneau RJ, Sciurba FC. Use of endobronchial valves for native lung hyperinflation associated with respiratory failure in a single-lung transplant recipient for emphysema. Chest 2007; 131 (1) 214-216
- 44 Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351 (9095) 24-27
- 45 De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20 (5) 518-524
- 46 Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002; 21 (2) 226-232
- 47 Stavem K, Bjørtuft O, Borgan O, Geiran O, Boe J. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant 2006; 25 (1) 75-84
- 48 Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009; 9 (7) 1640-1649
- 49 Thabut G, Ravaud P, Christie J , et al. Determinants of the survival benefit of lung transplantation in COPD patients. Am J Respir Crit Care Med 2008; 177 (10) 1156-1163
- 50 Lahzami S, Bridevaux PO, Soccal PM , et al. Survival impact of lung transplantation for COPD. Eur Respir J 2010; 36 (1) 74-80
- 51 King MB, Campbell EJ, Gray BH, Hertz MI. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients. Am J Respir Crit Care Med 1994; 149 (4 Pt 1) 966-971
- 52 Meyer KC, Nunley DR, Dauber JH , et al. Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med 2001; 164 (1) 97-102
- 53 Mal H, Guignabert C, Thabut G , et al. Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung transplant recipient. Am J Respir Crit Care Med 2004; 170 (7) 811-814
- 54 Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration 2006; 73 (2) 185-190
- 55 Oprescu N, McCormack FX, Byrnes S, Kinder BW. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry. Lung 2013; 191 (1) 35-42
- 56 Benden C, Rea F, Behr J , et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 2009; 28 (1) 1-7
- 57 Kpodonu J, Massad MG, Chaer RA , et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant 2005; 24 (9) 1247-1253
- 58 Boehler A, Speich R, Russi EW, Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996; 335 (17) 1275-1280
- 59 Pechet TT, Meyers BF, Guthrie TJ , et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004; 23 (3) 301-308
- 60 Reynaud-Gaubert M, Mornex JF, Mal H , et al. Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation 2008; 86 (4) 515-520
- 61 Machuca TN, Losso MJ, Camargo SM , et al. Lung transplantation for lymphangioleiomyomatosis: single-center Brazilian experience with no chylothorax. Transplant Proc 2011; 43 (1) 236-238
- 62 Groetzner J, Kur F, Spelsberg F , et al; Munich Lung Transplant Group. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 2004; 23 (5) 632-638
- 63 King-Biggs MB, Dunitz JM, Park SJ, Kay Savik S, Hertz MI. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 2003; 75 (9) 1437-1443
- 64 Bittmann I, Rolf B, Amann G, Löhrs U. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol 2003; 34 (1) 95-98
- 65 Karbowniczek M, Astrinidis A, Balsara BR , et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 2003; 167 (7) 976-982
- 66 Ohara T, Oto T, Miyoshi K , et al. Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. Ann Thorac Surg 2008; 86 (6) e7-e8
- 67 Chen F, Bando T, Fukuse T , et al. Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. Transplant Proc 2006; 38 (9) 3151-3153
- 68 Shigemura N, Kawamura T, Minami M , et al. Successful factor XIII administration for persistent chylothorax after lung transplantation for lymphangioleiomyomatosis. Ann Thorac Surg 2009; 88 (3) 1003-1006
- 69 Bhorade S, Ahya VN, Baz MA , et al. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med 2011; 183 (3) 379-387
- 70 Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans-cell histiocytosis. N Engl J Med 2000; 342 (26) 1969-1978
- 71 Dauriat G, Mal H, Thabut G , et al. Lung transplantation for pulmonary Langerhans cell histiocytosis: a multicenter analysis. Transplantation 2006; 81 (5) 746-750
- 72 Le Pavec J, Lorillon G, Jaïs X , et al. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest 2012; 142 (5) 1150-1157
- 73 Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans-cell histiocytosis in adults. N Engl J Med 2002; 346 (7) 484-490